ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
187 hedge funds and large institutions have $1.49B invested in Array Biopharma Inc in 2017 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 62 increasing their positions, 61 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
187
Holders Change
+20
Holders Change %
+11.98%
% of All Funds
4.66%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.1%
New
48
Increased
62
Reduced
61
Closed
21
Calls
$30.6M
Puts
$27.9M
Net Calls
+$2.74M
Net Calls Change
-$2.54M
Top Buyers
| 1 |
BlackRock
New York
|
$115M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
$152M |
| 3 |
Millennium Management
New York
|
$58.1M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
$33.8M |
| 5 |
Two Sigma Investments
New York
|
$20.4M |
Top Sellers
| 1 |
RG
Redmile Group
San Francisco,
California
|
$114M |
| 2 |
Morgan Stanley
New York
|
$3.12M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
$24.7M |
| 4 |
O
OrbiMed
New York
|
$127M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
$208M |
